We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current IMPL market cap is 949.56k. The company's latest EPS is USD -4.4784 and P/E is -0.05.
| Year End 31 December 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 668k | 12.65M |
| Operating Income | -41.57M | -45.33M | -71.49M | -83.18M |
| Net Income | -41.86M | -45.8M | -76.54M | -106.31M |
| Year End 31 December 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 42.27M | 12.06M | 97.91M | 88.55M |
| Total Liabilities | 8.32M | 18.52M | 45.4M | 132.71M |
| Total Equity | -91.7M | -133.5M | 52.51M | -44.16M |
| Year End 31 December 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -36.49M | -39.18M | -66.36M | -93.64M |
| Investing | -1.52M | -1.78M | -408k | -1.38M |
| Financing | 21k | 11.06M | 147.89M | 67.46M |
| Market Cap | 949.56k |
| Price to Earnings Ratio | -0.05 |
| Price to Sales Ratio | 0.45 |
| Price to Cash Ratio | 0.09 |
| Price to Book Ratio | -0.13 |
| Dividend Yield | - |
| Shares Outstanding | 23.74M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -82.61% |
| 52 Week High | 0.30 |
| 52 Week Low | 0.0212 |
| Spread (Intraday) | 0.12 (75.74%) |
| Company Name | Impel Pharmaceuticals Inc (PK) |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
